Dysregulation of cardiolipin biosynthesis in pediatric heart failure

Journal of Molecular and Cellular Cardiology

Volumn 74, Issue , 2014, Pages 251-259

  Chatfield, Kathryn C ^a   Sparagna, Genevieve C ^c   Sucharov, Carmen C ^b   Miyamoto, Shelley D ^a   Grudis, Jonathan E ^b   Sobus, Rebecca D ^b   Hijmans, Jamie ^b   Stauffer, Brian L ^b,c,d  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Cardiolipin; Dilated cardiomyopathy; Heart failure; Mitochondria; Pediatric

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN SYNTHASE; CYTIDINE DIPHOSPHATE DIACYLGLYCEROL INOSITOL 3 PHOSPHATIDYLTRANSFERASE; GLYCEROLPHOSPHATE PHOSPHATIDYLTRANSFERASE; PHOSPHATASE; PHOSPHATIDYLGLYCEROPHOSPHATASE; SYNTHETASE; UNCLASSIFIED DRUG; MITOCHONDRIAL PROTEIN;

ADULT; AGED; ARTICLE; CARDIOLIPIN DEPLETION; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPLETION; DISEASE ASSOCIATION; DISORDERS OF LIPID METABOLISM; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; LIPID COMPOSITION; LIPID DEGRADATION; LIPOGENESIS; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITOCHONDRIAL GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ADOLESCENT; AGE; BIOSYNTHESIS; CARDIOMYOPATHY, DILATED; CHEMISTRY; GENETICS; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE; HEART TRANSPLANTATION; HEART VENTRICLE; INFANT; METABOLISM; NEWBORN; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARDIOLIPINS; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; MYOCARDIUM;

EID: 84904746106     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.002     Document Type: Article

References (45)

1. Arola A., Jokinen E., Ruuskanen O., Saraste M., Pesonen E., Kuusela A.L., et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 1997, 146:385-393.
2. Hollander S.A., Bernstein D., Yeh J., Dao D., Sun H.Y., Rosenthal D. Outcomes of children following a first hospitalization for dilated cardiomyopathy. Circ Heart Fail 2012, 5:437-443.
3. Nugent A.W., Daubeney P.E.F., Chondros P., Carlin J.B., Cheung M., Wilkinson L.C., et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003, 348:1639-1646.
4. Lipshultz S.E., Sleeper L.A., Towbin J.A., Lowe A.M., Orav E.J., Cox G.F., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003, 348:1647-1655.
5. Kantor P.F., Abraham J.R., Dipchand A.I., Benson L.N., Redington A.N. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol 2010, 55:1377-1384.
6. Bublik N., Alvarez J.A., Lipshultz S.E. Pediatric cardiomyopathy as a chronic disease: a perspective on comprehensive care programs. Prog Pediatr Cardiol 2008, 25:103-111.
7. Rossano JW, Kim J, Decker JA, Price JF, Zafar F, Graves DE Increasing prevalence and hospital charges in pediatric heart failure related hospitalizations in the United States: a population-based study [abstract]. Circulation 2010, 122.
8. Lowry A.W., Knudson J.D., Cabrera A.G., Graves D.E., Morales D.L.S., Rossano J.W. Cardiopulmonary resuscitation in hospitalized children with cardiovascular disease: estimated prevalence and outcomes from the kids' inpatient database. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc 2013, 14:248-255.
9. Cubbon R.M., Gale C.P., Kearney L.C., Schechter C.B., Brooksby W.P., Nolan J., et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circ Heart Fail 2011, 4:396-403.
10. Blume E.D., Canter C.E., Spicer R., Gauvreau K., Colan S., Jenkins K.J. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol 2006, 27:336-342.
11. Harmon W.G., Sleeper L.A., Cuniberti L., Messere J., Colan S.D., Orav E.J., et al. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol 2009, 104:281-286.
12. ™ 1993, University of Washington, Seattle, Seattle (WA). R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam (Eds.).
13. Mohammed S., Bahitham W., Chan A., Chiu B., Bamforth F., Sergi C. Mitochondrial DNA related cardiomyopathies. Front Biosci (Elite Ed) 2012, 4:1706-1716.
14. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007, 356:1140-1151.
15. Rosca M.G., Vazquez E.J., Kerner J., Parland W., Chandler M.P., Stanley W., et al. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc Res 2008, 80:30-39.
16. Jaswal J.S., Keung W., Wang W., Ussher J.R., Lopaschuk G.D. Targeting fatty acid and carbohydrate oxidation-a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta 1813, 2011:1333-1350.
17. Pfeiffer K., Gohil V., Stuart R.A., Hunte C., Brandt U., Greenberg M.L., et al. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 2003, 278:52873-52880.
18. Schwall C.T., Greenwood V.L., Alder N.N. The stability and activity of respiratory complex II is cardiolipin-dependent. Biochim Biophys Acta Bioenerg 1817, 2012:1588-1596.
19. Zhang M., Mileykovskaya E., Dowhan W. Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 2002, 277:43553-43556.
20. Zhang M., Mileykovskaya E., Dowhan W. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J Biol Chem 2005, 280:29403-29408.
21. Schlame M., Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 2006, 580:5450-5455.
22. Zachman D.K., Chicco A.J., McCune S.A., Murphy R.C., Moore R.L., Sparagna G.C. The role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart. J Lipid Res 2010, 51:525-534.
23. Malhotra A., Edelman-Novemsky I., Xu Y., Plesken H., Ma J., Schlame M., et al. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome. Proc Natl Acad Sci U S A 2009, 106:2337-2341.
24. Chicco A.J., Sparagna G.C. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 2007, 292:C33-C44.
25. Sparagna G.C., Lesnefsky E.J. Cardiolipin remodeling in the heart. J Cardiovasc Pharmacol 2009, 53:290-301.
26. Kiebish M.A., Yang K., Sims H.F., Jenkins C.M., Liu X., Mancuso D.J., et al. Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency. J Biol Chem 2012, 287:25086-25097.
27. Kiebish M.A., Yang K., Liu X., Mancuso D.J., Guan S., Zhao Z., et al. Dysfunctional cardiac mitochondrial bioenergetic, lipidomic, and signaling in a murine model of Barth syndrome. J Lipid Res 2013, 54:1312-1325.
28. Sparagna G.C., Chicco A.J., Murphy R.C., Bristow M.R., Johnson C.A., Rees M.L., et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 2007, 48:1559-1570.
29. Chicco A.J., Sparagna G.C., McCune S.A., Johnson C.A., Murphy R.C., Bolden D.A., et al. Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets. Hypertension 2008, 52:549-555.
30. Mulligan C.M., Sparagna G.C., Le C.H., De Mooy A.B., Routh M.A., Holmes M.G., et al. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc Res 2012, 94:460-468.
31. Saini-Chohan H.K., Holmes M.G., Chicco A.J., Taylor W.A., Moore R.L., McCune S.A., et al. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J Lipid Res 2009, 50:1600-1608.
32. Sparagna G.C., Johnson C.A., McCune S.A., Moore R.L., Murphy R.C. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res 2005, 46:1196-1204.
33. Miyamoto S.D., Stauffer B.L., Nakano S., Sobus R., Nunley K., Nelson P., et al. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J 2014, 35:33-41.
34. Houtkooper R.H., Rodenburg R.J., Thiels C., van Lenthe H., Stet F., Poll-The B.T., et al. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Anal Biochem 2009, 387:230-237.
35. Taylor W.A., Mejia E.M., Mitchell R.W., Choy P.C., Sparagna G.C., Hatch G.M. Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation. PLoS One 2012, 7:e48628.
36. Lewin M.B., Timiras P.S. Lipid changes with aging in cardiac mitochondrial membranes. Mech Ageing Dev 1984, 24:343-351.
37. Lee H.-J., Mayette J., Rapoport S.I., Bazinet R.P. Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids Health Dis 2006, 5:2.
38. Lesnefsky E.J., Hoppel C.L. Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochim Biophys Acta 2008, 1777:1020-1027.
39. Lesnefsky E.J., Minkler P., Hoppel C.L. Enhanced modification of cardiolipin during ischemia in the aged heart. J Mol Cell Cardiol 2009, 46:1008-1015.
40. Ahuja P., Wanagat J., Wang Z., Wang Y., Liem D.A., Ping P., et al. Divergent mitochondrial biogenesis responses in human cardiomyopathy. Circulation 2013, 127:1957-1967.
41. Barth A.S., Kumordzie A., Frangakis C., Margulies K.B., Cappola T.P., Tomaselli G.F. Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ Cardiovasc Genet 2011, 4:475-483.
42. Sihag S., Li A.Y., Cresci S., Sucharov C.C., Lehman J.J. PGC-1? and ERR? target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol 2009, 46:201-212.
43. Lykidis A., Jackson P.D., Rock C.O., Jackowski S. The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content. J Biol Chem 1997, 272:33402-33409.
44. Mancuso D.J., Sims H.F., Han X., Jenkins C.M., Guan S.P., Yang K., et al. Genetic ablation of calcium-independent phospholipase A2γ leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype. J Biol Chem 2007, 282:34611-34622.
45. Mancuso D.J., Han X., Jenkins C.M., Lehman J.J., Sambandam N., Sims H.F., et al. Dramatic accumulation of triglycerides and precipitation of cardiac hemodynamic dysfunction during brief caloric restriction in transgenic myocardium expressing human calcium-independent phospholipase A2gamma. J Biol Chem 2007, 282:9216-9227.